CD19.20.22 CAR T-cells

· University of Maryland, Baltimore

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD19.20.22 CAR T-cells, covering 2025-09-11 to 2025-09-11. Get the full timeline:

Most recent: Clinical Trial Update: CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas [Phase 1]